Bios Fund III QP, LP
Bios Partners · adviser of record: Steelhead Capital Management, LLC · 2019 vintage
Bios Fund III QP, LP is a 2019 venture fund managed by Bios Partners, with $48mm raised (Form D, amount sold). It reported $81.8mm in gross assets at year-end 2025, 1.70x its size, against a peak of $86.4mm in 2023.
- Latest value held
- $81.8mm year-end 2025
- Peak
- $86.4mm year-end 2023
- Fund size
- $48mm Form D, amount sold
- Held vs. size
- 1.70x peak 1.80x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $81.8mm | 1.70x | -5% over 2 yrs |
| 2023 | $86.4mm | 1.80x | +8% |
| 2022 | $80.2mm | 1.67x | +37% |
| 2021 | $58.8mm | 1.22x | +36% |
| 2020 | $43.4mm | 0.90x | +36% |
| 2019 | $32mm | 0.67x | – |
Other funds from Bios Partners
- Bios Sirpant CO-Invest I, LP 2021
- Bios Actuate CO-Invest II, LP 2020
- Bios Onl CO-Invest I, LP 2020
- Bios Actuate CO-Invest III, LP 2020
- Bios Fund III NT, LP 2019
- Bios Lti CO-Invest III QP, LP 2018
- Bios Azitra CO-Invest I, LP 2018
- Bios Immusoft CO-Invest I, LP 2018
- Bios Actuate CO-Invest I, LP 2018
- Bios Fund II QP, LP 2017
- Bios Fund I, LP 2017
- Bios Fund II NT, LP 2017
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-6761344952. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.